HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$16.90
Day range
$16.60 - $17.18
Year range
$12.95 - $25.47
Market cap
1.53B USD
Avg Volume
563.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 145.00M | 480.00% |
Operating expense | 131.00M | 28.43% |
Net income | -4.00M | 95.00% |
Net profit margin | -2.76 | 99.14% |
Earnings per share | 0.19 | 117.03% |
EBITDA | 7.00M | 108.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 995.00M | 4.30% |
Total assets | 1.29B | 3.11% |
Total liabilities | 586.00M | -10.40% |
Total equity | 707.00M | — |
Shares outstanding | 90.95M | — |
Price to book | 2.17 | — |
Return on assets | 0.84% | — |
Return on capital | 1.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.00M | 95.00% |
Cash from operations | -2.00M | 97.96% |
Cash from investing | -169.00M | -231.01% |
Cash from financing | 229.00M | 22,800.00% |
Net change in cash | 58.00M | 81.25% |
Free cash flow | 43.88M | 187.10% |
About
Founded
2015
Website
Employees
577